跳至主要内容
临床试验/NCT03228407
NCT03228407Unknown不适用

Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)

McGuire Research Institute2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年4月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Correlation between the time from intravenous injection of fluorescein to visualization of fluorescein on probe based confocal endomicroscopy (pCLE) with esophageal permeability (i.e. - epithelial barrier function).

研究概览

简要总结

Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Investigator)

盲法说明

Investigator in the lab performing Ussing's chamber analysis will be blinded to the diagnosis of the patient

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Ability to give informed consent

排除标准

  • Esophageal varices
  • Prior esophageal or gastric surgery
  • Active gastrointestinal bleeding
  • Evidence of esophageal malignancy
  • Inability to provide informed consent

研究组 & 干预措施

Non-erosive reflux disease (NERD)

Active Comparator

Patient's with GERD refractory to PPI with no evidence of erosive esophagitis on endoscopy. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Confocal endomicroscopy (Procedure)

Non-erosive reflux disease (NERD)

Active Comparator

Patient's with GERD refractory to PPI with no evidence of erosive esophagitis on endoscopy. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Endoscopic biopsies (Diagnostic Test)

Non-erosive reflux disease (NERD)

Active Comparator

Patient's with GERD refractory to PPI with no evidence of erosive esophagitis on endoscopy. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Mucosal impedance (MI) (Diagnostic Test)

Barrett's esophagus/erosive esophagitis

Active Comparator

Patient's with Barrett's esophagus or with erosive esophagitis on endoscopy. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Confocal endomicroscopy (Procedure)

Barrett's esophagus/erosive esophagitis

Active Comparator

Patient's with Barrett's esophagus or with erosive esophagitis on endoscopy. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Endoscopic biopsies (Diagnostic Test)

Barrett's esophagus/erosive esophagitis

Active Comparator

Patient's with Barrett's esophagus or with erosive esophagitis on endoscopy. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Mucosal impedance (MI) (Diagnostic Test)

Control

Placebo Comparator

Patient's with no h/o GERD or Barrett's esophagus who are undergoing endoscopy for non-GERD related indication. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Confocal endomicroscopy (Procedure)

Control

Placebo Comparator

Patient's with no h/o GERD or Barrett's esophagus who are undergoing endoscopy for non-GERD related indication. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Endoscopic biopsies (Diagnostic Test)

Control

Placebo Comparator

Patient's with no h/o GERD or Barrett's esophagus who are undergoing endoscopy for non-GERD related indication. Confocal endomicroscopy, endoscopic biopsies and mucosal impedance (MI) will be performed.

干预措施: Mucosal impedance (MI) (Diagnostic Test)

结局指标

主要结局

Correlation between the time from intravenous injection of fluorescein to visualization of fluorescein on probe based confocal endomicroscopy (pCLE) with esophageal permeability (i.e. - epithelial barrier function).

时间窗: Through study completion, an average of 1 year.

次要结局

  • Compare the time from intravenous injection of fluorescein to visualization of fluorescein on probe based confocal endomicroscopy (pCLE) in patients with Barrett's esophagus and controls(Through study completion, an average of 1 year.)
  • Compare the time from intravenous injection of fluorescein to visualization of fluorescein on probe based confocal endomicroscopy (pCLE) in patients with symptoms of refractory GERD and Barrett's esophagus(Through study completion, an average of 1 year.)
  • Correlation between the Ussing's chamber findings (esophageal permeability) and confocal endomicroscopy findings of patients with symptoms of refractory GERD and Barrett's esophagus(Through study completion, an average of 1 year.)
  • Correlation between the Ussing's chamber findings (esophageal permeability) and confocal endomicroscopy findings of patients with symptoms of refractory GERD and controls(Through study completion, an average of 1 year.)
  • Correlation between the Ussing's chamber findings (esophageal permeability) and Mucosal impedance findings of patients with symptoms of refractory GERD and controls(Through study completion, an average of 1 year.)

研究者

发起方
McGuire Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验